Dr. Michael Lowe, MD
Claim this profileEmory University Hospital Midtown
Studies Skin Cancer
Studies Melanoma
6 reported clinical trials
13 drugs studied
Area of expertise
1Skin Cancer
Stage III
Stage IV
Stage II
2Melanoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Michael Lowe, MD is currently running
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
Neoadjuvant Daromun + Surgery
for Melanoma
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting2 awards Phase 318 criteria
More about Michael Lowe, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Michael Lowe, MD has experience with
- Ipilimumab
- Nivolumab
- VX15/2503
- Cemiplimab
- Wide Local Excision = 1cm Margin
- Wide Local Excision = 2cm Margin
Breakdown of trials Michael Lowe, MD has run
Skin Cancer
Melanoma
Cutaneous Melanoma
Squamous Cell Carcinoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Lowe, MD specialize in?
Michael Lowe, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage III patients, or patients who are Stage IV.
Is Michael Lowe, MD currently recruiting for clinical trials?
Yes, Michael Lowe, MD is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Michael Lowe, MD has studied deeply?
Yes, Michael Lowe, MD has studied treatments such as Ipilimumab, Nivolumab, VX15/2503.
What is the best way to schedule an appointment with Michael Lowe, MD?
Apply for one of the trials that Michael Lowe, MD is conducting.
What is the office address of Michael Lowe, MD?
The office of Michael Lowe, MD is located at: Emory University Hospital Midtown, Atlanta, Georgia 30308 United States. This is the address for their practice at the Emory University Hospital Midtown.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.